Nanozymes as Emerging Therapeutics for Asthma: A Redox-Responsive and Immunomodulatory Strategy

Asthma is a chronic, etiologically diverse lung disease that contributes to worldwide morbidity and healthcare burdens. Although bronchodilators and corticosteroids remain the cornerstones of asthma treatment, their long-term use is associated with significant side effects. Furthermore, steroid resi...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Manar T. El-Morsy, Nadine M. Askar, Ali Emad Khurkhash, Nagm Al-Din Mahrous, Yusuf Ahmed Elberry, Mohamed Ramadan Sayed, Norhan Ashraf Ahmed, Rowayda A. Ahmed, Yehia S. Mohamed, Sinclair Steele, Ahmad Ahmeda, Rudaynah Mohamed, Doaa S. R. Khafaga
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2026-05-01
Serie:	Biomedicines
Soggetti:	nanozymes asthma nanotechnology immunotherapy redox responsive
Accesso online:	https://www.mdpi.com/2227-9059/14/5/1107
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!